OPB-111077
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for OPB-111077, covering 2016-04-05 to 2026-04-08. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1 Trial of OPB-111077 in Combination With Bendamustine and Rituximab in Patients With r/r DLBCL [Phase 1]